Link Cell Therapies
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
220 E Grand Ave, South San Francisco, Ca...Website
www.linkcelltx.comRevenue
$5.9 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
2
1
1
1
1
About Link Cell Therapies
Link Cell Therapies is a biotechnology company based in South San Francisco, California, founded in 2022 by Robbie Majzner, MD, and Crystal Mackall, MD, at Stanford University. Links proprietary logic-gating technologies enable the safe targeting of multiple antigens that are selectively co-expressed on cancer cells, reducing the risk of on-target, off-tumor toxicity.Explore more
Link Cell Therapies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Link Cell Therapies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Link Cell Therapies
Earning: See what the market has to say on Link Cell Therapies recently announced quarterly report
Product Launch: Get notified when Link Cell Therapies launches new products
Check out if Link Cell Therapies is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Link Cell Therapies has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Link Cell Therapies had a recent Job posting/layoffs
Link Cell Therapies, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Link Cell Therapies has new funding data
Recommended Actions
Reach out to Masked Content who joined Link Cell Therapies as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Link Cell Therapies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Link Cell Therapies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Link Cell Therapies.
Link Cell Therapies financials insights
Gather financial insights about Link Cell Therapies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$60M
Link Cell Therapies Tech Stack
A closer look at the technologies used by Link Cell Therapies
Link Cell Therapies News & Media
Link Cell Therapies Announces $60M Series A Financing
SOUTH SAN FRANCISCO, CA, Link Cell Therapies, an oncology cell therapy company, announced its official launch from stealth with a $60 million Series A financing.J&J leads $60 million Series A for newly-launched Link Cell | The Pharmaletter
Link Cell Therapies, an oncology cell therapy company, has announced its official launch from stealth with a $60 million Series A financing that was led by Johnson & Johnson.Link Cell Therapies Launches with Vision of Advancing CAR-T Therapies in Solid and Liquid Tumors
Closes $60 Million Series A Financing Round Backed by New and Existing Investors $92 Million Raised to Date Across Seed and Series A Financings SOUTH SAN FRANCISCO, Calif., Dec. 15, 2025 /PRNewswire/ -- Link Cell Therapies ("Link"), an oncology cell therapy company, today announced its...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Link Cell Therapies
Sign Up For FreeTo access detailed company insights
Link Cell Therapies is a biotechnology company based in South San Francisco, California, founded in 2022 by Robbie Majzner, MD, and Crystal Mackall, MD, at Stanford University. Links proprietary logic-gating technologies enable the safe targeting of multiple antigens that are selectively co-expressed on cancer cells, reducing the risk of on-target,... Read More
